Reporting owner

GREY MICHAEL G

Reporting owner CIK 0001240122 · Director

View SEC filings ↗

These transactions appear in filings associated with this reporting owner. Jointly reported quantities and amounts are unallocated; they are not this owner's individual purchases or total holdings. Names and roles reflect the relevant filing, and a reporting owner may be a person or an organization.

Reset

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

9 dated transactions · 1 of 1 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Dec 19, 2025Mirum Pharmaceuticals, Inc.Common StockGREY MICHAEL GExercise / conversion
Dec 11, 2025SPRUCE BIOSCIENCES, INC.Stock Option (Right to Buy)GREY MICHAEL GStock award
Dec 11, 2025SPRUCE BIOSCIENCES, INC.Stock Option (Right to Buy)GREY MICHAEL GStock award
Dec 11, 2025SPRUCE BIOSCIENCES, INC.Stock Option (right to buy)GREY MICHAEL GStock award
Dec 11, 2025SPRUCE BIOSCIENCES, INC.Stock Option (Right to Buy)GREY MICHAEL GStock award
Dec 11, 2025SPRUCE BIOSCIENCES, INC.Stock Option (Right to Buy)GREY MICHAEL GStock award
Dec 11, 2025SPRUCE BIOSCIENCES, INC.Stock Option (Right to Buy)GREY MICHAEL GStock award
Dec 1, 2025Mirum Pharmaceuticals, Inc.Common StockGREY MICHAEL GExercise / conversion
Nov 21, 2025Mirum Pharmaceuticals, Inc.Common StockGREY MICHAEL GExercise / conversion

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Transactions in associated filings

Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedCompanyReporting ownersType / securityQuantityPrice / reference valueDetails
Trade: Mirum Pharmaceuticals, Inc.MIRM · company listingsExercise / conversionCommon StockNon-derivative security · Code M50,0002.936Value: 146,800Currency not specifiedView ↗
Trade: SPRUCE BIOSCIENCES, INC.SPRB · company listings
GREY MICHAEL GExecutive Chairman · Director
Stock awardStock Option (Right to Buy)Derivative security · Code A400Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: SPRUCE BIOSCIENCES, INC.SPRB · company listings
GREY MICHAEL GExecutive Chairman · Director
Stock awardStock Option (Right to Buy)Derivative security · Code A666Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: SPRUCE BIOSCIENCES, INC.SPRB · company listings
GREY MICHAEL GExecutive Chairman · Director
Stock awardStock Option (right to buy)Derivative security · Code A133Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: SPRUCE BIOSCIENCES, INC.SPRB · company listings
GREY MICHAEL GExecutive Chairman · Director
Stock awardStock Option (Right to Buy)Derivative security · Code A1,499Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: SPRUCE BIOSCIENCES, INC.SPRB · company listings
GREY MICHAEL GExecutive Chairman · Director
Stock awardStock Option (Right to Buy)Derivative security · Code A1,255Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: SPRUCE BIOSCIENCES, INC.SPRB · company listings
GREY MICHAEL GExecutive Chairman · Director
Stock awardStock Option (Right to Buy)Derivative security · Code A387Not reported *Value: Not reportedCurrency not specifiedView ↗
Trade: Mirum Pharmaceuticals, Inc.MIRM · company listingsExercise / conversionCommon StockNon-derivative security · Code M50,0002.936Value: 146,800Currency not specifiedView ↗
Trade: Mirum Pharmaceuticals, Inc.MIRM · company listingsExercise / conversionCommon StockNon-derivative security · Code M50,0002.936Value: 146,800Currency not specifiedView ↗